Differential effects of oxidized LDL on apolipoprotein AI and B synthesis in HepG2 cells

Free Radical Biology and Medicine

Volumn 41, Issue 5, 2006, Pages 786-796

  Bourdon, Emmanuel ^a   Loreau, Nadine ^a   Lagrost, Laurent ^a   Davignon, Jean ^b   Bernier, Lise ^b   Blache, Denis ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

ApoAI; ApoB; Atherosclerosis; Free radicals; HepG2 cells; LDL oxidation; LDL HDL ratio; Lipid biosynthesis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEUCINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; TRITIUM;

ARTICLE; ATHEROGENESIS; CELL STRAIN HEPG2; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIPOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CELL LINE; CHOLESTEROL ESTERS; FREE RADICALS; HUMANS; LEUCINE; LIPIDS; LIPOPROTEINS, LDL; OXYGEN; RNA, MESSENGER; TIME FACTORS; TRIGLYCERIDES;

EID: 33746675580     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.05.028     Document Type: Article

References (57)

1. Assmann G., Cullen P., Jossa F., Lewis B., and Mancini M. International Task Force for Prevention of Coronary Heart Disease. Reducing the risk-The scientific background to primary and secondary prevention of coronary heart disease, a worldwide view. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1819-1824
2. Hussain M.M., Strickland D.K., and Bakillah A. The mammalian low-density lipoprotein receptor family. Annu. Rev. Nutr. 19 (1999) 141-172
3. Olofsson S.-O., Bjurssell G., Boström K., Carlson P., Elovson J., Protter A.A., Reuben M.A., and Bondjers G. Apolipoprotein B: structure, biosynthesis and role in the lipoprotein assembly process. Atherosclerosis 68 (1987) 1-17
4. Steinberg D. Role of oxidized LDL and antioxidants in atherosclerosis. Adv. Exp. Med. Biol. 369 (1995) 39-48
5. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320 (1989) 915-924
6. Esterbauer H., Gebicki J., Puhl H., and Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13 (1992) 341-390
7. De Backer G., De Bacquer D., and Kornitzer M. Epidemiological aspects of high density lipoprotein cholesterol. Atherosclerosis 137 (1998) S1-S6
8. Martinez L.O., Jacquet S., Terce F., Collet X., Perret B., and Barbaras R. New insight on the molecular mechanisms of high-density lipoprotein cellular interactions. Cell Mol. Life Sci 61 (2004) 2343-2360
9. Johnson W.J., Mahlberg F.H., Rothblat G.H., and Phillips M.C. Cholesterol transport between cells and high-density lipoproteins. Biochim. Biophys. Acta Lipids Lipid Metab. 1085 (1991) 273-298
10. Parthasarathy S., Barnett A.H., and Fong L.G. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta 1044 (1990) 275-283
11. Kauser K., and Rubanyi G.M. Potential cellular signaling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen. J. Vasc. Res. 34 (1997) 229-236
12. Mackness M.I., and Durrington P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 115 (1995) 243-253
13. Cappola A.R., and Ladenson P.W. Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88 (2003) 2438-2444
14. Packard C.J. Understanding coronary heart disease as a consequence of defective regulation of apolipoprotein B metabolism. Curr. Opin. Lipidol. 10 (1999) 237-244
15. Ginsberg H.N. Insulin resistance and cardiovascular disease. J. Clin. Invest 106 (2000) 453-458
16. Duvillard L., Pont F., Florentin E., Gambert P., and Verges B. Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus. Atherosclerosis 152 (2000) 229-237
17. Bourdon E., Loreau N., Davignon J., Bernier L., and Blache D. Involvement of oxysterols and lysophosphatidylcholine in the oxidized LDL-induced impairment of serum albumin synthesis in HepG2 cells. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2643-2650
18. Hatch F.T. Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6 (1968) 1-68
19. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150 (1985) 76-85
20. Basu S.K., Goldstein J.L., Anderson R.G.W., and Brown M.S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc. Natl. Acad. Sci. USA 73 (1976) 3178-3182
21. El-Saadani M., Esterbauer H., El-Sayed M., Goher M., Nassar A.Y., and Jürgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30 (1989) 627-630
22. Blache D., Rodriguez C., and Davignon J. Pro-oxidant effects of 7-hydroperoxycholest-5-en-3β-ol on the copper-initiated oxidation of low density lipoprotein. FEBS Lett. 357 (1995) 135-139
23. Blache D., Durand P., Girodon F., Gesquière L., and Loreau N. Determination of sterols, oxysterols and fatty acids of phospholipids in cells and lipoproteins: a one sample method. J. Am. Oil Chem. Soc. 75 (1998) 107-113
24. Folch J., Lees M., and Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
25. Hill T.B., and Whatley S. A simple, rapid microassay for DNA. FEBS Lett. 56 (1975) 20-23
26. Fredenrich A., Giroux L.M., Tremblay M., Krimbou L., Davignon J., and Cohn J.S. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. J. Lipid Res. 38 (1997) 1421-1432
27. Kempen H.J., Imbach A.P., Giller T., Neumann W.J., Hennes U., and Nakada N. Secretion of apolipoproteins A-I and B by HepG2 cells: regulation by substrates and metabolic inhibitors. J. Lipid Res. 36 (1995) 1796-1806
28. Shoulders C.C., Kornblihtt A.R., Munro B.S., and Barralle F. Gene structure of human apolipoprotein A-I. Nucleic Acids Res. 11 (1983) 2827-2837
29. Karathanasis S.K., Zannis V.I., and Breslow J.L. Isolation and characterization of the human apolipoprotein A-I gene. Proc. Natl. Acad. Sci. USA 89 (1983) 6147-6151
30. Tso J.Y., Sun X.-H., Kao T., Reece K.S., and Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13 (1985) 2485-2502
31. Darnfors C., Nilsson J., Protter A.A., Carlson P., Talmud P.J., Humphries S.E., Whalstrom J., Wiklund O., and Bjurssell G. RFLPs for the human apolipoprotein B gene: HincII and PvuII. Nucleic Acids Res. 14 (1986) 7135
32. Hara A., and Radin N.S. Lipid extraction of tissues with a low-toxicity solvent. Anal. Biochem. 90 (1978) 220-226
33. Knowles B.B., Howe C.C., and Aden D.P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209 (1980) 497-499
34. Boström K., Wettesten M., Boren J., Bondjers G., Wiklund O., and Olofsson S.-O. Pulse-chase studies of the synthesis and intracellular transport of apolipoprotein B100 in HepG2 cells. J. Biol. Chem. 261 (1986) 13800-13806
35. Harris W.S., Windsor S.L., and Caspermeyer J.J. Modification of lipid-related atherosclerosis risk factors by omega3 fatty acid ethyl esters in hypertriglyceridemic patients. J. Nutr. Biochem. 4 (1993) 706-712
36. Rader D.J., Hoeg J.M., and Brewer Jr. H.B. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann. Intern. Med. 120 (1994) 1012-1025
37. Duvillard L., Pont F., Florentin E., Galland-Jos C., Gambert P., and Verges B. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study. Eur. J. Clin. Invest. 30 (2000) 685-694
38. Barter P.J., and Rye K.A. High density lipoproteins and coronary heart disease. Atherosclerosis 121 (1996) 1-12
39. Holvoet P., and Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 8 (1994) 1279-1284
40. Schneider M., Verges B., Klein A., Miller E.R., Deckert V., Desrumaux C., Masson D., Gambert P., Brun J.M., Fruchart-Najib J., Blache D., Witztum J.L., and Lagrost L. Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity. Diabetes 53 (2004) 2633-2639
41. Kita T., Nagano Y., Yokode M., Ishii K., Kume N., Ooshima A., Yoshida H., and Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA 84 (1987) 5928-5931
42. Carew T.E., Schwenke D.C., and Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA 84 (1987) 7725-7729
43. Girodon F., Blache D., Monget A.L., Lombart M., Brunet-Lecompte P., Arnaud J., Richard M.J., and Galan P. Effect of two year supplementation with low dose antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and on antioxidant defense parameters. J. Am. Coll. Nutr. 16 (1997) 357-365
44. Berliner J.A., and Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20 (1996) 707-727
45. Cominacini L., Garbin U., Pasini A.F., Davoli A., Campagnola M., Contessi G.B., Pastorino A.M., and Lo Cascio V. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radic. Biol. Med. 22 (1997) 117-127
46. Brown A.M., Wiggins D., and Gibbons G.F. Manipulation of cholesterol and cholesteryl ester synthesis has multiple effects on the metabolism of apolipoprotein B and the secretion of very-low-density lipoprotein by primary hepatocyte cultures. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1440 (1999) 253-265
47. Dashti N., Franklin F.A., and Abrahamson D.R. Effect of ethanol on the synthesis and secretion of apoA-I- and apoB-containing lipoproteins in HepG2 cells. J. Lipid Res. 37 (1996) 810-824
48. Pan M., Cederbaum A.I., Zhang Y.L., Ginsberg H.N., Williams K.J., and Fisher E.A. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J. Clin. Invest. 113 (2004) 1277-1287
49. Burnett J.R., Wilcox L.J., and Huff M.W. Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion. Clin. Chim. Acta 286 (1999) 231-242
50. Cheng D., Chang C.C.Y., Qu X., and Chang T.Y. Activation of acyl-coenzyme A:cholesterol acyltransferase by cholesterol or by oxysterol in a cell-free system. J. Biol. Chem. 270 (1995) 685-695
51. Nagy L., Tontonoz P., Alvarez J.G.A., Chen H., and Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR gamma. Cell 93 (1998) 229-240
52. Gesquière L., Loreau N., Minnich A., Davignon J., and Blache D. Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells. Free Radic. Biol. Med. 27 (1999) 134-145
53. Lusis A.J., and Navab M. Lipoprotein oxidation and gene expression in the artery wall: new opportunities for pharmacologic intervention in atherosclerosis. Biochem. Pharmacol. 46 (1993) 2119-2126
54. Schmitt A., Nègre-Salvayre A., Troly M., Valdiguié P., and Salvayre R. Phospholipid hydrolysis of mildly oxidized LDL reduces their cytotoxicity to cultured endothelial cells: potential protective role against atherogenesis. Biochim. Biophys. Acta Lipids Lipid Metab. 1256 (1995) 284-292
55. Berliner J., Leitinger N., Watson A., Huber J., Fogelman A., and Navab M. Oxidized lipids in atherogenesis: formation, destruction and action. Thromb. Haemostasis 78 (1997) 195-199
56. Acton S., Scherer P.E., Lodish H.F., and Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269 (1994) 21003-21009
57. Plump A.S., Scott C.J., and Breslow J.L. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E- deficient mouse. Proc. Natl. Acad. Sci. USA 91 (1994) 9607-9611